THE PAST YEAR HAS BEEN ONE OF SIGNIFICANT GROWTH FOR FREDERICK'S LIFE SCIENCE SECTOR.
We compiled a list of some of the major local expansion and success stories below.
BIOFACTURA
In February 2021, BioFactura announced a contract option activation of over $13 million by the Biomedical Advanced Research and Development Authority (BARDA) as part of BioFactura’s prime contract valued at up to $67.4 million for the advanced development of a smallpox biodefense therapeutic. While smallpox was declared eradicated in 1980 by the World Health Organization after an extensive vaccination campaign, the threat of bioterrorism and/or inadvertent release remains. This product has the potential to fulfill an unmet need in preparedness, augment current medical countermeasures and guard against potential resistance.